<DOC>
	<DOCNO>NCT02199028</DOCNO>
	<brief_summary>This research study examines effect hyaluronidase length time insulin infusion set wear . The aim study improve length time infusion set worn infuse hyaluronidase directly insulin infusion site . The investigator also assess accuracy Dexcom G4 Platinum ( G4P ) sensor extend sensor wear beyond 7 day FDA approve time frame .</brief_summary>
	<brief_title>Hyaluronidase Effect Infusion Set Life</brief_title>
	<detailed_description>The investigator would like see use hyaluronidase improve insulin infusion set survival improve onset insulin action . The investigator also assess accuracy Dexcom G4P sensor extend site use beyond 7 day FDA approve time frame . The use sensor information combine knowledge infuse insulin pump therapy could potentially help u detect infusion set begin fail . Information sensor function point failure , sensor function response Tylenol may allow u develop special formula determine sensor work well . This important create artificial pancreas . You invited participate research study see use hyaluronidase improve insulin infusion set survival improve onset insulin action . The investigator also assess accuracy Dexcom G4P sensor extend site use beyond 7 day FDA approve time frame . Eligible subject type 1 diabetes wear insulin pump . Thirty subject enrol . Fifteen patient two site : Stanford University University Colorado .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Clinical diagnosis type 1 diabetes least one year use insulin pump least 3 month 2 . Total daily insulin dose least 0.4 units/kg/day 3 . The diagnosis type 1 diabetes base investigator 's judgment ; C peptide level antibody determination need . 4 . Age 12 45 year 5 . Hemoglobin A1c level less equal 10 % 6 . Willingness infuse 1 ml hyaluronidase ( Hylenex ) insulin infusion set insertion day 1 day 3 week assign use hyaluronidase 7 . Willingness use Silhouette Comfort insulin infusion set throughout study . The set include Duo Infusion Tubing infusion hyaluronidase ( Hylenex ) . 8 . Willingness eat breakfast morning first two week study 9 . Willing take two 500mg tablet Tylenol Regular Strength monitor glucose level Â½ , 1 , 2 , 4 , 6 , 8 hour later . 10 . For female , currently know pregnant 11 . An understanding willingness follow protocol sign inform consent 12 . Must able understand speak write English 1 . Diabetic ketoacidosis past 6 month 2 . Severe hypoglycemia result seizure loss consciousness 6 month prior enrollment 3 . Known tape allergies 4 . Current treatment seizure disorder 5 . Cystic fibrosis 6 . Active infection 7 . A known medical condition judgment investigator might interfere completion protocol follow example : 8 . Inpatient psychiatric treatment past 6 month either subject subject 's primary care giver ( i.e. , parent guardian ) 9 . Presence known adrenal disorder 10 . If antihypertensive , thyroid , antidepressant lipid lower medication , lack stability medication past 2 month prior enrollment study 11 . Abuse alcohol 12 . Use OmniPod insulin infusion pump 13 . Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>hyaluronidase</keyword>
	<keyword>infusion set</keyword>
	<keyword>insulin pump</keyword>
	<keyword>Continuous glucose monitor</keyword>
</DOC>